1 / 23

Percutaneous mitral valve repair using the MitraClip® device (e-valve)

Post-script. Percutaneous mitral valve repair using the MitraClip® device (e-valve). Angela Hoye , Rajesh Nair, Farqad Alamgir Castle Hill Hospital, Hull. No conflict of interest in relation to this presentation. Mitral regurgitation occurs due to: valvular degeneration (50%)

Albert_Lan
Download Presentation

Percutaneous mitral valve repair using the MitraClip® device (e-valve)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Post-script Percutaneous mitral valve repair using the MitraClip® device (e-valve) • Angela Hoye,Rajesh Nair, Farqad Alamgir • Castle Hill Hospital, Hull

  2. No conflict of interest in relation to this presentation

  3. Mitral regurgitation occurs due to: valvular degeneration (50%) rheumatic disease (20%) ischaemia (17%) Where possible, surgical mortality is lower following MV repair rather than replacement However, after MV repair surgery, published data show a rate of recurrence of grade 3 or 4 MR of 17-20% at 5 yrs Introduction: MR

  4. Anatomy

  5. The surgical “edge-to-edge” technique was first described in early 1990`s (Alfieri) Over 1,500 pts reported in the literature Safe, effective, durable No occurrence of mitral stenosis Facilitates proper leaflet coaptation Degenerative - anchor flail / prolapsing leaflets Functional - Coapt tethered leaflets to reduce time and force required to close valve Creates tissue bridge The Alfieri technique

  6. The Alfieri technique • Euro Heart Survey demonstrated that despite presence of severe MR and symptoms, HALF of all patients are not considered for surgery • CE Mark approval in March 2008

  7. MitraClip® procedure overview

  8. Sufficient leaflet tissue for mechanical coaptation Non-rheumatic/endocarditic valve morphology Anatomic considerations Flail gap <10mm Flail width <15mm Mitral Area > 4.0cm Coaptation length > 2mm >2mm >11mm <10mm <15mm Anatomic SuitabilityLeaflet mal-coaptation resulting in MR

  9. Studies • 47 sites

  10. Age 18 years or older Moderate to severe (3+) or severe (4+) MR Symptomatic Asymptomatic with LVEF < 60% or LVESD > 40mm* MR originates from A2-P2 mal-coaptation Candidate for mitral valve surgery Key exclusions: EF < 25% or LVESD > 55 mm Renal insufficiency Endocarditis, rheumatic heart disease Data: EVEREST *ACC/AHA Guidelines, Circ. 114;450,2006

  11. EVEREST I + roll-in phase of EVEREST II Results One or more Clips implanted in 90% of cases

  12. Clinical results 99% 97% Survival 96% 96% 96% 92% 89% Freedom from surgery 86% 85% 82% 84% 75% 67% 66% 65% 63% Freedom from death, surgery & MR > 2+

  13. LV Dysfunction Population (EF < 55% or LVIDs > 4.5cm) Reverse LV remodelling

  14. All potential patients were discussed at MDT Pre-procedural TTE and TOE to determine suitability Teamwork is vital Interventional cardiologist Cardiac anaesthetist ECHO specialist Lab staff – specialist training given to nursing staff All procedures performed with support from physicians from the company Our experience

  15. Successfully treated 3 patients, all with degenerative MR 2 pts with a single clip, 1 with 2 clips No procedural MACE At 1 month, all patients report a marked improvement in symptoms / exercise capacity Our experience

  16. Amplatz Guide

  17. Preliminary results of percutaneous mitral valve repair with the MitraClip® demonstrate that it is safe and feasible Steep learning curve and it is essential to understand MV anatomy and TOE images Definite place for this technology in a subset of patients with MR and suitable anatomy All potential candidates should be evaluated by a multidisciplinary team Patient selection is paramount Conclusions

More Related